The Second Affiliated Hospital of Dalian Medical University
Clinical Trials
13
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Irinotecan Liposome(II) Combined with Ivonescimab As Second-line Treatment for Small Cell Lung Cancer : a Prospective, Single-arm, Multicenter Clinical Study
- Conditions
- SCLC
- Interventions
- Drug: irinotecan liposome(II) plus Ivonescimab via intravenously (IV) Q3W for 4-6 cycles, followed by Ivonescimab until disease progression or intolerable toxicity
- First Posted Date
- 2025-02-11
- Last Posted Date
- 2025-02-11
- Target Recruit Count
- 40
- Registration Number
- NCT06820762
- Locations
- 🇨🇳
The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China
🇨🇳Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
Effect of Frontal Transcranial Direct Current Stimulation on BDNF in Stroke Patients With Cognitive Impairment
- Conditions
- Stroke
- First Posted Date
- 2024-04-26
- Last Posted Date
- 2024-05-21
- Target Recruit Count
- 40
- Registration Number
- NCT06386614
- Locations
- 🇨🇳
Department of Rehabilitation Medicine, the Second Hospital of Dalian Medical University, DaLian, Liaoning, China
🇨🇳Lily, Dalian, Liaoning, China
Effect of Modified Air-pulse Stimulation on Tracheotomised Patients With Dysphagia After Stroke
- Conditions
- Stroke
- First Posted Date
- 2024-03-08
- Last Posted Date
- 2024-03-08
- Target Recruit Count
- 42
- Registration Number
- NCT06299904
- Locations
- 🇨🇳
the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China
The Effects of tDCS Combined With rTMS on Post-stroke Cognitive Impairment
- Conditions
- Stroke
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2024-02-12
- Target Recruit Count
- 60
- Registration Number
- NCT06252987
- Locations
- 🇨🇳
Lily, Dalian, Liaoning, China
Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage
- Conditions
- Lung Cancer
- First Posted Date
- 2023-02-01
- Last Posted Date
- 2023-02-01
- Target Recruit Count
- 2064
- Registration Number
- NCT05707585
- Locations
- 🇨🇳
Zongda Hospital affiliated to Southeast University, Nanjing, Jiangsu, China
🇨🇳The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China
🇨🇳Zhongshan Hospital Fudan University, Shanghai, China
- Prev
- 1
- 2
- 3
- Next